NCT00032786 Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease Status COMPLETED Phase PHASE3
NCT00031642 Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT00031083 Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas Status COMPLETED Phase PHASE1
NCT00030966 Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00027300 Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00005592 Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00000721 An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive Status COMPLETED Phase PHASE1
NCT00000659 A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC) Status TERMINATED Phase PHASE2